Given that excessive cytokine secretion is a primary driver of CAR-associated toxicities like cytokine release syndrome (CRS), these findings suggest that NKG2D-DAP12 may offer a more tolerable CAR-T cell design. Here, TYROBP is linked to congenital rubella syndrome.